Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
74.57
-0.68 (-0.90%)
Nov 28, 2025, 1:00 PM EST - Market closed
Henry Schein Employees
Henry Schein had 25,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
25,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$517,520
Profits / Employee
$15,640
Market Cap
8.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25,000 | 0 | - |
| Dec 31, 2023 | 25,000 | 3,000 | 13.64% |
| Dec 31, 2022 | 22,000 | 400 | 1.85% |
| Dec 25, 2021 | 21,600 | 2,600 | 13.68% |
| Dec 26, 2020 | 19,000 | 0 | - |
| Dec 28, 2019 | 19,000 | 1,000 | 5.56% |
| Dec 29, 2018 | 18,000 | -4,000 | -18.18% |
| Dec 30, 2017 | 22,000 | 1,000 | 4.76% |
| Dec 31, 2016 | 21,000 | 2,000 | 10.53% |
| Dec 26, 2015 | 19,000 | 1,500 | 8.57% |
| Dec 27, 2014 | 17,500 | 1,500 | 9.38% |
| Dec 28, 2013 | 16,000 | 1,000 | 6.67% |
| Dec 29, 2012 | 15,000 | 0 | - |
| Dec 31, 2011 | 15,000 | 1,500 | 11.11% |
| Dec 25, 2010 | 13,500 | 1,000 | 8.00% |
| Dec 26, 2009 | 12,500 | 0 | - |
| Dec 27, 2008 | 12,500 | 500 | 4.17% |
| Dec 29, 2007 | 12,000 | 1,000 | 9.09% |
| Dec 30, 2006 | 11,000 | 0 | - |
| Dec 31, 2005 | 11,000 | 1,400 | 14.58% |
| Dec 25, 2004 | 9,600 | 1,700 | 21.52% |
| Dec 27, 2003 | 7,900 | 1,000 | 14.49% |
| Dec 28, 2002 | 6,900 | 400 | 6.15% |
| Dec 29, 2001 | 6,500 | 250 | 4.00% |
| Dec 30, 2000 | 6,250 | -250 | -3.85% |
| Dec 25, 1999 | 6,500 | 500 | 8.33% |
| Dec 26, 1998 | 6,000 | 2,800 | 87.50% |
| Dec 28, 1997 | 3,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HSIC News
- 3 days ago - Artisan Select Equity Fund Q3 2025 Portfolio Review - Seeking Alpha
- 5 days ago - Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting - Business Wire
- 10 days ago - American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades - Seeking Alpha
- 12 days ago - Henry Schein, Inc. (HSIC) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - Worried About an AI Bubble? Here Are BofA's Top Stock Picks to Diversify Your Portfolio - Investopedia
- 17 days ago - Henry Schein to Participate in Upcoming Investor Conference in December - Business Wire
- 18 days ago - Henry Schein, Inc. (HSIC) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too? - The Motley Fool